Healthcare · Drug Manufacturers Specialty Generic · NASDAQ
| Market cap | $18.87B |
|---|---|
| Trailing P/E | 6.5 |
| FCF yield | 9.6% |
| Revenue growth (YoY) | -3.0% |
| EPS growth (YoY) | -10.9% |
| FCF/share growth (YoY) | -3.0% |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Drug Manufacturers Specialty Generic |
Viatris Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Rob Bresnahan | House | Sell | $1,001 - $15,000 | Apr 8, 2025 |
| Rob Bresnahan | House | Buy | $1,001 - $15,000 | Feb 25, 2025 |
| Daniel Goldman | House | Buy | $1,001 - $15,000 | Feb 9, 2023 |
| Earl Blumenauer | House | Sell | $1,001 - $15,000 | Mar 14, 2022 |
| Debbie Dingell | House | Sell | $1,001 - $15,000 | Jun 21, 2021 |
| Carol Devine Miller | House | Sell | $1,001 - $15,000 | Apr 1, 2021 |
| Peter Meijer | House | Sell | $1,001 - $15,000 | Feb 19, 2021 |
| Josh Gottheimer | House | Sell | $1,001 - $15,000 | Jan 5, 2021 |
| Gilbert Cisneros | House | Exchange | $1,001 - $15,000 | Dec 14, 2020 |
| Josh Gottheimer | House | Buy | $1,001 - $15,000 | Dec 8, 2020 |
| Mo Brooks | House | Sell | $1,001 - $15,000 | Dec 1, 2020 |
| Debbie Dingell | House | Exchange | $1,001 - $15,000 | Nov 23, 2020 |